"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

Celltrion's asthma treatment Omlyclo, a biosimilar of Novartis's Xolair, has received Canadian approval for chronic urticaria, rhinosinusitis, and allergic asthma ...

A new study published in the Ear, Nose and Throat Journal found that the severity of chronic rhinosinusitis with nasal ...

IT’S that time of year where we’re greeted by a cacophony of coughs, sneezes and sniffles wherever we go. You might think a cough is a cough, but different conditions will produce a ...

"I was first diagnosed I think I was 11 or 12."That was devastating for Scott Hedgpeth who has always loved being active and ...

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.

For example, some people may have an allergic reaction to it and require treatment. 23 Similarly, some issues that lead to congestion may not be treatable simply by moisturizing the nasal cavity ...

Their scrutiny of 24 trials involving 3,695 participants evaluating different long Covid remedies led to their deduction which stated: "Moderate certainty evidence suggests that a programme of CBT ...

In the case of nasal polyps or tumors, there is no way to prevent them from developing. The focus is on treatment when they do arise. Ear candles are hollowed-out fabric cones wrapped in wax. Some ...